Alzheimer's Talks

A free teleconference series offered by UsAgainstAlzheimer's covering a wide range of topics with leaders in the Alzheimer's community. If you're interested in sponsoring a call, email hjameson@usagainstalzheimers.org.

Latest Talks

Thumbnail
October 24, 2017

"Still Alice" and an XPRIZE for Alzheimer's - Author Lisa Genova

The guest on October’s Alzheimer’s Talks was Lisa Genova, a neuroscientist and author whose work explores what it is like to live with neurological diseases and disorders. Her bestselling books include Still Alice, Inside the O’Briens, Left Neglected, and Love Anthony. Still Alice, about a Harvard professor with early onset Alzheimer’s disease, became a highly acclaimed movie.

Lisa Genova talked with George Vradenburg about how...

Thumbnail
September 8, 2017

Alzheimer's Clinical Trials & Barriers Among Diverse Communities - Dr. Goldie Byrd, Daisy Duarte & Valerie Smith

September’s Alzheimer’s Talks focused on the importance of clinical trials, particularly to better understand the motivations of and barriers to participation among diverse communities. This call was hosted by Jason Resendez, director of the LatinosAgainstAlzheimer’s network, and Dr. Goldie Byrd, Director of the Center for Outreach in Alzheimer’s Aging and Community Health at North Carolina A&T State University.

Dr. Byrd’s work focuses on Alzheimer’s in African American communities, both...

Thumbnail
June 28, 2017

Alzheimer's Research at the National Institute on Aging - Dr. Laurie Ryan

Dr. Laurie Ryan was our guest for the June Alzheimer’s Talks. Dr. Ryan is Chief of the Dementias of Aging Branch in the Division of Neuroscience at the National Institute on Aging, which is part of the National Institutes of Health (NIH). At the National Institute on Aging, she directs Alzheimer’s disease clinical trials research.

Dr. Ryan discussed efforts and plans to improve the pace and quality of clinical trials...

Thumbnail
May 25, 2017

Redefining a "Meaningful" Alzheimer's Drug - Dr. Howard Fillit

Dr. Howard Fillit joined George Vradenburg for this month’s Alzheimer’s Talks to discuss a new report he co-authored, “Single Endpoint for New Drug Approvals for Alzheimer’s Disease”. The report proposes a change in how we define a clinically meaningful drug and therefore the framework for FDA approvals of a possible Alzheimer’s treatment.

Dr. Fillit is the Founding Executive Director and Chief Science Officer at the Alzheimer’s Drug Discovery Foundation...